Predicting the risk of the distant recurrence of cervical cancer after concurrent chemoradiation: A validation study of the Korean Gynecologic Oncologic Group (KGOG)-1024 model.

MLA

Shin, Wonkyo, et al. “Predicting the Risk of the Distant Recurrence of Cervical Cancer after Concurrent Chemoradiation: A Validation Study of the Korean Gynecologic Oncologic Group (KGOG)-1024 Model.” Gynecologic Oncology, vol. 164, no. 1, Jan. 2022, pp. 62–67. EBSCOhost, https://doi.org/10.1016/j.ygyno.2021.10.070.

APA

Shin, W., Park, S.-Y., Seo, S.-S., Lim, M. C., Kim, J.-Y., & Kang, S. (2022). Predicting the risk of the distant recurrence of cervical cancer after concurrent chemoradiation: A validation study of the Korean Gynecologic Oncologic Group (KGOG)-1024 model. Gynecologic Oncology, 164(1), 62–67. https://doi.org/10.1016/j.ygyno.2021.10.070

Chicago

Shin, Wonkyo, Sang-Yoon Park, Sang-Soo Seo, Myong Cheol Lim, Joo-Young Kim, and Sokbom Kang. 2022. “Predicting the Risk of the Distant Recurrence of Cervical Cancer after Concurrent Chemoradiation: A Validation Study of the Korean Gynecologic Oncologic Group (KGOG)-1024 Model.” Gynecologic Oncology 164 (1): 62–67. doi:10.1016/j.ygyno.2021.10.070.